Filter posts

Roll Call: Patient-Centeredness, Comparative Effectiveness, and Value

In Roll Call, Tony Coelho former House Majority Whip, Chairman of the Partnership to Improve …

Wall Street Journal: Patients Deserve Better

In case you missed it, The Wall Street Journal published my Letter to the Editor …

WSJ Article Cherry Picks Cost, Ignores Value of Medicines

Today’s Wall Street Journal story, “Price Increases Drive Drug Firms’ Revenue” reaffirms that old chestnut, …

Wall Street Journal: The Assault on Drug Innovation

Today, the Wall Street Journal published an editorial commenting on yesterday’s proposed plan by Secretary Hillary Clinton’s …

Ezekiel Emanuel's Flawed Solution

In a New York Times op-ed today, Dr. Ezekiel Emanuel proposes “The Solution to Drug …

Rx Response Changes Name to Healthcare Ready

Yesterday, Rx Response announced that its name will be changing to Healthcare Ready. For nearly nine …

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?

In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in …

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Building a new franchise in a therapeutic from scratch poses a host of challenges, from …

Wednesday Recap of BIO 2015: What the Official Bloggers Have to Say

Everyday our BIO Official Bloggers, writers who are on top of the biotechnology beat, release …

Dr. Eric Topol's Insights on Wearables, Smart Phones, Digital Medicine Revolution

Dr. Eric Topol, director of the Scripps Translational Science Institute, is widely recognized for many …